PMID: 3790639Jan 1, 1987Paper

High-dose naltrexone therapy and dietary counseling for obesity

Biological Psychiatry
J E MitchellD N Pfohl

Abstract

There is considerable evidence that antagonism of the endogenous opioids will suppress food intake in a variety of animal species. The authors report a double-blind, placebo-controlled trial of the long-acting, orally active narcotic antagonist naltrexone in the promotion of weight loss in obese male subjects who were also undergoing dietary counseling for weight reduction. Subjects received medication (naltrexone, 300 mg/day or placebo) for 8 weeks following an initial 2-week single-blind placebo phase. The results failed to demonstrate an advantage for the active drug. However, the naltrexone was associated with hepatotoxicity when used at this dosage in this population.

References

Feb 13, 1982·Lancet·H A SternbachM S Gold
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J E MorleyM T Lowy
Nov 1, 1983·Peptides·J E Morley, A S Levine
Sep 12, 1980·Science·J E Morley, A S Levine
May 1, 1982·Psychosomatic Medicine·C P O'BrienJ W Ternes
May 9, 1983·Life Sciences·J E MorleyN E Rowland
Jan 1, 1984·Psychopharmacology·P Deviche, G Schepers
Jan 1, 1983·Statistical Bulletin
Aug 1, 1983·Pharmacology, Biochemistry, and Behavior·C L McLaughlin, C A Baile
Jan 1, 1981·Psychopharmacology·D J Sanger, P S McCarthy
Mar 1, 1983·Physiology & Behavior·J E MorleyU S Seal
Mar 1, 1983·Appetite·E Trenchard, T Silverstone
Jun 16, 1980·Life Sciences·M T LowyG K Yim
Jul 1, 1982·The Journal of Clinical Endocrinology and Metabolism·R L Atkinson
Mar 19, 1982·Science·A MandenoffD L Margules
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·D J Sanger, P S McCarthy
Jun 1, 1982·Physiology & Behavior·A S LevineB S Handwerger
Aug 1, 1981·Drug and Alcohol Dependence·L E HollisterH K Gillespie
Nov 2, 1981·Life Sciences·J E Morley, A S Levine

Citations

Jan 1, 1990·Psychopharmacology·Martin R YeomansJ A Critchley
Jul 4, 2012·Psychopharmacology·Samuel R ChamberlainPradeep J Nathan
Apr 29, 2010·Current Diabetes Reports·Frank L Greenway, G A Bray
Nov 15, 2001·Current Psychiatry Reports·G O'LearyR D Weiss
Jan 1, 1990·Life Sciences·C J BillingtonJ E Morley
Jan 1, 1987·Physiology & Behavior·T A SpiegelE Stellar
Mar 1, 1988·Pharmacology, Biochemistry, and Behavior·A S LevineJ E Morley
Nov 1, 1990·Pharmacology, Biochemistry, and Behavior·D L DeHaven-HudkinsL R Steranka
Sep 1, 1991·Pharmacology, Biochemistry, and Behavior·M M HetheringtonB J Rolls
Nov 1, 1987·Peptides·G A OlsonA J Kastin
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·B H Herman
Nov 1, 1995·Addictive Behaviors·A Drewnowski
Jun 23, 2000·Biological Psychiatry·R S SchottenfeldT R Kosten
Aug 1, 1996·Physiology & Behavior·Martin R Yeomans, R W Gray
Dec 14, 2002·Neuroscience and Biobehavioral Reviews·Martin R Yeomans, Richard W Gray
Aug 26, 1998·Journal of Pain and Symptom Management·P Compton
Apr 15, 2006·Clinical Neuropharmacology·Suck Won KimR P Remmel
Mar 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·M CampbellM Nobler
Sep 13, 2001·International Clinical Psychopharmacology·S W Kim, J E Grant
Jan 1, 1989·Annals of the New York Academy of Sciences·A S Levine, C J Billington
Mar 26, 2011·Journal of Opioid Management·David J MyselsMaria A Sullivan
Feb 28, 2006·Alcoholism, Clinical and Experimental Research·Joi L DunbarKenneth C Lasseter
Mar 30, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Julia M A SinclairDavid S Baldwin
Jul 15, 2006·Alcohol·Mao-Hsiung YenJau-Shyong Hong
Mar 24, 2009·Alcoholism, Clinical and Experimental Research·Andrea KingTracie Wilcox
Jun 22, 2011·Expert Opinion on Pharmacotherapy·Sonja K Billes, Frank L Greenway
Apr 29, 2014·Expert Opinion on Drug Safety·Jessica L Verpeut, Nicholas T Bello
Mar 11, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ian A MendezNiall P Murphy
May 13, 2009·The International Journal of Neuropsychopharmacology·Pradeep J Nathan, Edward T Bullmore
Jul 13, 2016·CNS Drugs·Elias Aboujaoude, Wael O Salame
Jun 1, 2012·Obesity Facts·Ruben NogueirasCarlos Diéguez
Jun 22, 2010·Expert Opinion on Emerging Drugs·Michael Soyka, Susanne Rösner
Jul 2, 2005·Critical Reviews in Toxicology·Jennie L WalgrenDavid C Thompson
Feb 22, 2017·Alimentary Pharmacology & Therapeutics·E T Goh, M Y Morgan
Nov 18, 2006·Journal of Clinical Psychopharmacology·Helen M PettinatiCharles A Dackis
Nov 1, 1988·Diabetes/metabolism Reviews·G A Bray, D S Gray
Oct 16, 2010·Journal of Pediatric Gastroenterology and Nutrition·Aglaia ZellosKathleen B Schwarz
Dec 22, 1999·Endocrine Reviews·G A Bray, Frank L Greenway
Oct 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Frank L GreenwayNB-201 Study Group
May 17, 2019·Expert Opinion on Drug Safety·Nicholas T Bello
Apr 15, 2009·Expert Opinion on Pharmacotherapy·Raymond A PlodkowskiSachiko St Jeor
May 13, 2014·The Journal of Pharmacology and Experimental Therapeutics·John R Cashman, Marc R Azar
Oct 4, 2019·Science Advances·K WitkiewitzL Leggio
Jan 5, 2002·Journal of Clinical Psychopharmacology·S W KimR P Remmel
Jul 25, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity·Kishore M Gadde, David B Allison
Feb 1, 1989·Journal of Endocrinological Investigation·J E Morley
May 9, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Michael A StatnickMark L Heiman
Jan 30, 2009·The Journal of Nutrition·Marcia Levin Pelchat
Apr 6, 2016·Clinical Neuropharmacology·Gihyun YoonJoseph Westermeyer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.